Literature DB >> 17155905

Inhibition of infectious human immunodeficiency virus type 1 virions via lentiviral vector encoded short antisense RNAs.

Shuo Gu1, Jianfei Ji, James D Kim, Jiing-Kuan Yee, John J Rossi.   

Abstract

During the life cycles of most retroviruses and lentiviruses, dimerization and packaging of two copies of viral genomic RNA is required for the subsequent conversion of RNA into double stranded DNA by reverse transcriptase. For human immunodeficiency virus type 1 (HIV-1), dimerization is mediated by interactions of the stem-loop structures in the dimerization-packaging, or psi (Psi) domain. We have tethered anti-HIV gag ribozymes and small antisense RNAs to the HIV Psi domain in an HIV-1 lentiviral vector to facilitate copackaging of these replication inhibitors with HIV genomic RNAs during HIV infectious challenge. In order to maximize the base pairing of the ribozymes or antisense segments to the HIV-1 genomic target, sequences in HIV-1 were identified that are highly accessible to antisense pairing. Ribozymes or antisense RNAs designed to target these sequences were inserted in the lentiviral vector at the same relative distance to the Psi element as the HIV-1 target sites. Packaged vectors were transduced into CEM cells followed by challenges with HIV-1. Only the constructs that harbored short antisense segments complementary to HIV-1 gag produced replication incompetent HIV-1. These results demonstrate that a short stretch of antisense pairing downstream of the dimerization domain in an HIV-based vector can drive dimerization and provide a powerful approach for inhibition of HIV-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17155905     DOI: 10.1089/oli.2006.16.287

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  6 in total

1.  Potential inhibition of HIV-1 encapsidation by oligoribonucleotide-dendrimer nanoparticle complexes.

Authors:  Raveen Parboosing; Louis Chonco; Francisco Javier de la Mata; Thavendran Govender; Glenn Em Maguire; Hendrik G Kruger
Journal:  Int J Nanomedicine       Date:  2017-01-04

2.  Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles.

Authors:  Jerlisa Ann C Arizala; Mayumi Takahashi; John C Burnett; Dominique L Ouellet; Haitang Li; John J Rossi
Journal:  AIDS Res Hum Retroviruses       Date:  2018-07-05       Impact factor: 2.205

Review 3.  Nucleic acids-based therapeutics in the battle against pathogenic viruses.

Authors:  Joost Haasnoot; Ben Berkhout
Journal:  Handb Exp Pharmacol       Date:  2009

4.  Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs.

Authors:  Shuo Gu; Lan Jin; Feijie Zhang; Peter Sarnow; Mark A Kay
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

5.  Disruption of Specific RNA-RNA Interactions in a Double-Stranded RNA Virus Inhibits Genome Packaging and Virus Infectivity.

Authors:  Teodoro Fajardo; Po-Yu Sung; Polly Roy
Journal:  PLoS Pathog       Date:  2015-12-08       Impact factor: 6.823

Review 6.  Unmasking the information encoded as structural motifs of viral RNA genomes: a potential antiviral target.

Authors:  Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Rev Med Virol       Date:  2013-08-27       Impact factor: 6.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.